Kineticos consists of entrepreneurs, operators, and investors with successful exits.
Leveraging our expertise, network, ecosystem, and capital, Kineticos provides the most
relevant insights and recommendations for our portfolio companies, building value
every step of the way.
We partner with entrepreneurs and early-stage companies that offer unique, innovative, and IP-protected products and services with a focus on oncology, neurosciences, rare diseases, and antimicrobial resistance (AMR).Learn More
"Since the early days of Promaxo, Kineticos has been an important ally. They have consistently focused on our needs and helped us advance our innovative modular MRI platform. Kineticos’ business and scientific acumen has resonated with our team."Dr. Amit Vohra | Founder and CEO, Promaxo
"The support from Kineticos Ventures and their network has been crucial for Inceptor Bio. Our Board members representing Kineticos Ventures are generous with their time and energy and consistently provide constructive, actionable feedback to our leadership team. We are grateful to have such truly invested investors!"Management Team | Inceptor Bio
"We have appreciated the input from Kineticos as hands on and supportive investors. Frank and the team have been helpful in making introductions and leveraging their network."Dr James McIlroy MBChB BMedSci (Hons) | CEO, EnteroBiotix
Leveraging our roots as a consultant, Kineticos can provide consulting services to portfolio companies. Capabilities include: